Kilitch Drugs Financials
NSE: KILITCH | BSE: 524500
₹201.02
As on 21-Sep-2026 12:54IST
Market cap
₹695 Cr
Revenue (TTM)
₹237 Cr
P/E Ratio
23.1
P/B Ratio
2.5
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
237.21
|
235.47
|
198.32
|
154.37
|
139.60
|
114.23
|
|||||
|
Total Income
|
248.79
|
246.72
|
209.48
|
158.85
|
142.52
|
117.14
|
|||||
|
Total Expenditure
|
200.94
|
198.15
|
166.57
|
130.11
|
121.87
|
103.73
|
|||||
|
EBITDA
|
36.27
|
37.33
|
31.74
|
24.26
|
17.73
|
10.50
|
|||||
|
Depreciation
|
3.87
|
3.62
|
3.11
|
3.35
|
3.55
|
2.47
|
|||||
|
EBIT
|
32.40
|
33.70
|
28.63
|
20.91
|
14.18
|
8.04
|
|||||
|
Interest
|
4.91
|
6.29
|
5.32
|
6.04
|
5.08
|
1.33
|
|||||
|
Other Income
|
11.58
|
11.24
|
11.16
|
4.48
|
2.92
|
2.91
|
|||||
|
Exceptional Items
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Profit before Tax
|
39.07
|
38.65
|
34.47
|
19.35
|
12.01
|
9.61
|
|||||
|
Provision for Tax
|
9.86
|
9.15
|
9.53
|
5.78
|
3.73
|
3.40
|
|||||
|
Profit after Tax
|
29.20
|
29.50
|
24.94
|
13.58
|
8.28
|
6.21
|
|||||
|
Minority Interest
|
0.85
|
0.67
|
1.76
|
1.03
|
2.17
|
1.15
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
30.05
|
30.17
|
26.70
|
14.60
|
10.45
|
7.37
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
279.65
|
279.65
|
202.33
|
176.29
|
151.60
|
139.09
|
|||||
|
Minority Interest
|
0.85
|
-2.79
|
-1.87
|
-0.62
|
-1.02
|
1.21
|
|||||
|
Non-Current Liabilities
|
59.28
|
54.70
|
25.14
|
-2.39
|
-1.91
|
-1.24
|
|||||
|
Current Liabilities
|
121.60
|
121.60
|
84.31
|
64.22
|
68.87
|
69.28
|
|||||
|
Total Liabilities
|
457.75
|
457.75
|
312.78
|
240.06
|
219.52
|
209.85
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
235.55
|
230.97
|
135.99
|
91.51
|
91.14
|
94.23
|
|||||
|
Current Assets
|
222.20
|
222.20
|
173.92
|
145.99
|
126.40
|
114.10
|
|||||
|
Total Assets
|
457.75
|
457.75
|
312.78
|
240.06
|
219.52
|
209.85
|
|||||
|
Total Debt*
|
--
|
88.71
|
49.42
|
31.65
|
22.19
|
20.43
|
|||||
|
Net Current Assets
|
100.60
|
100.60
|
89.61
|
81.78
|
57.53
|
44.83
|
|||||
|
Contingent Liabilities
|
--
|
0.76
|
0.76
|
0.76
|
0.76
|
0.76
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
23.96
|
17.54
|
-1.53
|
2.59
|
5.78
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-100.44
|
-39.95
|
-8.16
|
7.92
|
-15.25
|
|||||
|
Cash from Financing Activities
|
--
|
82.45
|
13.24
|
8.81
|
-0.72
|
7.03
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
5.97
|
-9.16
|
-0.88
|
9.78
|
-2.44
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
12.21
|
8.63
|
8.12
|
4.44
|
3.28
|
2.31
|
|||||
|
Cash EPS (₹)
|
8.60
|
9.47
|
8.53
|
5.15
|
3.72
|
2.73
|
|||||
|
Adjusted Book Value (₹)
|
80.45
|
79.89
|
61.45
|
53.53
|
45.92
|
42.78
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
6.85
|
10.91
|
-0.95
|
1.66
|
3.71
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-22.45
|
-17.69
|
-8.60
|
-4.40
|
-3.02
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
14.50
|
17.31
|
13.30
|
10.26
|
7.26
|
|||||
|
ROE (%)
|
11.02
|
12.26
|
13.20
|
8.43
|
5.86
|
4.73
|
|||||
|
ROA (%)
|
7.58
|
7.73
|
9.11
|
5.97
|
3.89
|
3.03
|
|||||
|
EBIT Margin (%)
|
13.66
|
14.31
|
14.44
|
13.55
|
10.16
|
7.03
|
|||||
|
Net Margin (%)
|
11.74
|
11.96
|
11.91
|
8.55
|
5.81
|
5.30
|
|||||
|
Cash Profit Margin (%)
|
--
|
14.07
|
14.14
|
10.96
|
8.48
|
7.60
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
14.04
|
18.74
|
28.47
|
10.58
|
22.20
|
66.71
|
|||||
|
EBIT Growth (%)
|
9.51
|
17.71
|
36.93
|
47.48
|
76.44
|
141.38
|
|||||
|
Net Profit Growth (%)
|
7.34
|
18.28
|
83.72
|
63.90
|
33.30
|
64.97
|
|||||
|
EPS Growth (%)
|
0.89
|
6.21
|
82.86
|
35.41
|
41.82
|
99.55
|
|||||
|
Book Value Growth (%)
|
--
|
38.28
|
14.80
|
20.30
|
7.35
|
7.46
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
23.13
|
14.78
|
10.65
|
42.02
|
20.81
|
35.47
|
|||||
|
Price / Book Value
|
2.47
|
1.60
|
2.88
|
3.56
|
1.49
|
1.92
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
16.03
|
10.66
|
14.47
|
22.23
|
10.64
|
20.26
|
|||||
|
Close Price (₹)
|
194.73
|
124.45
|
177.42
|
190.29
|
68.11
|
81.88
|
|||||
|
High Price (₹)
|
250.00
|
250.00
|
198.14
|
229.97
|
107.13
|
135.24
|
|||||
|
Low Price (₹)
|
117.25
|
117.25
|
143.83
|
66.81
|
59.35
|
39.02
|
|||||
|
Market Cap (₹ Cr)
|
695.04
|
445.94
|
581.29
|
626.97
|
217.45
|
261.31
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.21
|
0.32
|
0.24
|
0.18
|
0.15
|
0.15
|
|||||
|
Short term debt to equity ratio
|
--
|
0.11
|
0.11
|
0.18
|
0.15
|
0.15
|
|||||
|
Current Ratio
|
1.83
|
1.83
|
2.06
|
2.27
|
1.84
|
1.65
|
|||||
|
Quick Ratio
|
1.73
|
1.73
|
1.88
|
2.21
|
1.81
|
1.57
|
|||||
|
Interest Coverage
|
8.96
|
7.14
|
7.48
|
4.21
|
3.36
|
8.22
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
50.66
|
51.04
|
42.73
|
40.96
|
38.89
|
36.25
|
|||||
|
Asset Turnover
|
0.62
|
0.62
|
0.72
|
0.68
|
0.66
|
0.56
|
|||||
|
Receivable days
|
--
|
158.82
|
136.16
|
138.92
|
125.11
|
102.77
|
|||||
|
Inventory Days
|
--
|
20.79
|
17.76
|
7.13
|
9.21
|
13.72
|
|||||
|
Payable days
|
--
|
193.60
|
139.16
|
153.61
|
204.43
|
269.21
|
|||||
|
Cash Conversion Cycle
|
--
|
-13.99
|
14.76
|
-7.56
|
-70.11
|
-152.72
|